Social networks
1,200Activities
Technologies
Entity types
Location
60 Leonard Ave, Toronto, ON M5T 2R1, Canada
Toronto
Canada
Employees
Scale: 11-50
Estimated: 15
Engaged corporates
0Added in Motherbase
4 years, 11 months agoTREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology platform.
Alzheimer's disease, Parkinson's disease, ALS, protein misfolding diseases, drug discovery, and computer-aided drug design
Treventis™ Corporation is dedicated to treating and preventing protein misfolding diseases, utilizing Common Conformational Morphology (CCM).